Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
kabonk's Profile
Displaying 1-50 of 238 result(s).
CYDY CytoDyn Inc
05/07/2025 10:35:48 AM
Thanks. You're the best. I forgot a (11)
CYDY CytoDyn Inc
05/06/2025 11:44:03 PM
Not sure if they ever disclosed rec (5)
CYDY CytoDyn Inc
05/05/2025 2:28:23 PM
CCR5 bound by leronlimab would have (5)
CYDY CytoDyn Inc
08/20/2024 3:41:55 PM
Agree, there is lots of jibberish o (8)
CYDY CytoDyn Inc
08/13/2024 4:52:30 PM
Agree with you that the primary end (15)
CYDY CytoDyn Inc
08/13/2024 1:33:54 PM
Q: Are we hoping to improve upon th (11)
CYDY CytoDyn Inc
06/04/2024 12:08:14 PM
No, VIR is developing broadly neutr (7)
CYDY CytoDyn Inc
05/16/2024 3:07:46 PM
Ha, good questions and observations (1)
CYDY CytoDyn Inc
05/16/2024 2:34:44 PM
I wondered the same (new priority o (4)
CYDY CytoDyn Inc
05/16/2024 1:39:46 PM
Good to see some progress on trial (4)
CYDY CytoDyn Inc
05/15/2023 3:02:38 PM
It's nice that pubmed links to the (2)
CYDY CytoDyn Inc
05/15/2023 2:09:25 PM
Except the mice with disabled CCR5 (5)
CYDY CytoDyn Inc
12/19/2022 4:10:16 PM
Stiff person's syndrome neurodiagno (5)
CYDY CytoDyn Inc
12/14/2022 11:14:13 PM
Lipid nanoparticles encapsulation l (4)
CYDY CytoDyn Inc
12/14/2022 4:19:42 PM
Only problem with AAV transgene pro (9)
CYDY CytoDyn Inc
10/28/2022 10:36:32 PM
HIV patients with NASH is an area o
CYDY CytoDyn Inc
08/08/2022 10:59:26 PM
Hahaha, a rhetorical question. For (1)
CYDY CytoDyn Inc
08/03/2022 9:06:33 AM
Sorry .. can't edit on phone .. thi
CYDY CytoDyn Inc
08/03/2022 9:00:54 AM
I think the Sasha grant was a Cente
CYDY CytoDyn Inc
07/27/2022 6:25:59 PM
Nice writeup. In the news recently (7)
CYDY CytoDyn Inc
07/11/2022 12:25:58 PM
This will be in monkeys, like Sacha (6)
CYDY CytoDyn Inc
07/05/2022 5:37:52 PM
Yes I think they have already had s (1)
CYDY CytoDyn Inc
07/05/2022 8:08:07 AM
Unfortunately, AAV is not currently (4)
CYDY CytoDyn Inc
07/05/2022 12:44:26 AM
No, only one daughter cell would ge (3)
CYDY CytoDyn Inc
05/13/2022 2:37:48 PM
FDA is another corrupt failed burea (3)
CYDY CytoDyn Inc
04/01/2022 1:57:30 PM
The reason for the clinical hold wa (2)
CYDY CytoDyn Inc
03/31/2022 9:08:19 PM
Nice .. 7 years of safe monotherapy (3)
CYDY CytoDyn Inc
02/28/2022 4:27:24 PM
Well, the analysis probably is wron (6)
CYDY CytoDyn Inc
02/28/2022 2:32:57 PM
Great question, and it's too bad th (8)
CYDY CytoDyn Inc
02/17/2022 5:46:12 PM
Dark matter is not repulsive. Not s (1)
CYDY CytoDyn Inc
02/17/2022 5:27:41 PM
For the record, Rathke admitted to (1)
CYDY CytoDyn Inc
02/17/2022 4:49:29 PM
No, take a closer look at it. Take (3)
CYDY CytoDyn Inc
02/17/2022 3:53:32 PM
Forever is a very long time for a s (4)
CYDY CytoDyn Inc
02/17/2022 3:42:20 PM
Another review article from that si (5)
CYDY CytoDyn Inc
02/16/2022 1:01:19 PM
There are some long lived memory T- (1)
CYDY CytoDyn Inc
02/15/2022 2:38:37 PM
Patterson recently posted prelimina (7)
CYDY CytoDyn Inc
02/14/2022 12:00:41 PM
Nice review of chemokine signaling (6)
CYDY CytoDyn Inc
02/02/2022 12:37:39 PM
Lots of options/possibilities for f
CYDY CytoDyn Inc
02/02/2022 12:08:16 PM
I wonder if this financing is someh
CYDY CytoDyn Inc
01/31/2022 4:40:40 PM
They stopped recruiting for all the (8)
CYDY CytoDyn Inc
01/28/2022 2:11:50 PM
Which part do you take as speculati (1)
CYDY CytoDyn Inc
01/28/2022 1:46:28 PM
The 11/27/22 8-K says (b) On Januar (3)
CYDY CytoDyn Inc
01/28/2022 12:43:33 PM
Thanks for pulling this out. One ve (1)
CYDY CytoDyn Inc
01/26/2022 9:43:41 PM
Bingo: Its possible that the cytoki (4)
CYDY CytoDyn Inc
01/25/2022 11:33:51 AM
Several other therapies that work . (2)
CYDY CytoDyn Inc
01/20/2022 11:24:12 AM
Canceled CC, waiting for updates on (5)
CYDY CytoDyn Inc
01/15/2022 1:57:59 PM
Cash bond is because Amarex claims (3)
CYDY CytoDyn Inc
01/12/2022 1:15:58 PM
Nice article. Agree that Omicron in (7)
CYDY CytoDyn Inc
01/11/2022 11:31:08 AM
Unfortunately, 10-Q page 35 says: I (4)
CYDY CytoDyn Inc
01/10/2022 11:40:15 AM
Regnum is now run by Anne Kirby, fo (3)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Bitget Expands Its Influence in Southeast Asia's Crypto Scene
  • Tesla's Upcoming Shareholder Proposals on xAI Investment Strategies
  • Reckitt Benckiser Investors: Join the Class Action Today!
  • Exploring China's Economic Resilience Amid Global Challenges
  • Investors Alert: Join Class Action Against Reckitt Benckiser
  • Investigation Opportunities for Hims & Hers Health Shareholders
  • Investors Alert: Lawsuit Against Tempus AI Affects Shareholders
  • Investors Urged to Claim Losses in Neogen Corporation Lawsuit
  • Reinforcing Trilateral Environmental Collaboration in North America
  • Mercury Insurance to Extend Homeowners Coverage for Californians
  • Klotho Neurosciences, Inc. Innovates for Healthy Aging and Longevity
  • Flywire Corporation Faces Class Action: All You Need to Know
  • Understanding the Easterly ROCMuni Fund Class Action: Key Insights
  • Arnold & Itkin Takes Legal Action Against Chevron Over Explosion
  • Paul Mueller Company Revamps Earnings Report for 2025
  • Westbridge Renewable Energy's Strategic Share Consolidation Details
  • Investigation into Data Breach Claims for Tea App Users
  • Traction Uranium Secures Funding of Up to C$833,400 for Expansion
  • Diginex Moves Forward with Bonus Shares and Shareholder Decisions
  • Faircourt Asset Management Details July Fund Distribution
  • Unveiling Investigations into Crocs, Inc. Stockholder Rights
  • Essential Guide to Enjoying Summer with CASEKOO's Magic Stand
  • Nutex Health Faces Scrutiny After Blue Orca Capital Report
  • Caribou Biosciences Explores Legal Options for Shareholders
  • Chipotle Faces Legal Scrutiny: What Investors Should Know
  • The Growth of $100 in Danaher Corporation Over the Years
  • Unveiling The Stunning Growth of Tesla's Stock Value
  • Black Pearl Equities Initiates Tender Offer for Regional Health Shares
  • ISS Endorses Merger Between Regional Health Properties and SunLink
  • Grupo Bafar Reports Strong Second Quarter Performance in 2025
  • Black Pearl Equities Expands Investment Opportunities for RHEP Shares
  • Investor Alert: Atkore Inc. Under Investigation for Misconduct
  • Legal Investigation Announced for Acadia Healthcare Stockholders
  • Transforming $1000 in RTX into a Profitable Investment Journey
  • Investors Have Chance to Participate in Luminar Lawsuit
  • Exploring Devon Energy's Stock Growth Over Five Years
  • Lombard Street Capital and Lithium Africa's Strategic Merger
  • A Look at Reinsurance Group's Remarkable Growth Over 5 Years
  • Understanding Investor Rights Amid Semler Scientific Disputes
  • Insights into Tungray Technologies Inc and Investor Rights
  • Critical Legal Actions Impacting Fiserv Investors This Year
  • VineBrook Homes Trust Cancels Annual Stockholder Meeting
  • Empowering REALTORS with Innovative Tools for Success
  • Significant Growth of Laureate Education Stock Over Five Years
  • ChoiceCash Launches Online Auto Equity Loans in Hawaii
  • Investors May Drive Securities Fraud Class Action for Mutual Funds
  • Oscar Health: Navigating the Storm in Health Insurance Market
  • Discovering Hidden Gems: Stocks Beyond the S&P 500 Limelight
  • ServiceNow Set to Disrupt with Its AI-Fueled Growth
  • Empowering Real Estate Agents with New Partnership Tools
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site